Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 154 institutions that hold shares in the stock, with a total of 109 Million shares, which have been reported (via 13F filing form) to have a value of $322 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
27,525,640
shares
|
$81.2 Million
0.76% of portfolio
|
Q1 2024
Added 20.15%
|
|
|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
12,894,703
shares
|
$38 Million
0.03% of portfolio
|
Q3 2024
Reduced 41.15%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
10,624,185
shares
|
$31.3 Million
0.03% of portfolio
|
Q3 2024
Reduced 0.08%
|
|
|
Prosight Management, LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
9,079,539
shares
|
$26.8 Million
6.31% of portfolio
|
Q3 2024
Added 285.93%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
4,590,103
shares
|
$13.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.19%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
4,547,315
shares
|
$13.4 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.68%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
4,180,768
shares
|
$12.3 Million
0.26% of portfolio
|
Q3 2021
Reduced 32.82%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2024 Q3 2024 |
4,105,095
shares
|
$12.1 Million
0.15% of portfolio
|
Q2 2023
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,803,477
shares
|
$11.2 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.49%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
2,946,703
shares
|
$8.69 Million
0.01% of portfolio
|
Q3 2024
Added 70.47%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,533,635
shares
|
$7.47 Million
0.02% of portfolio
|
Q3 2024
Added 22.91%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
2,300,000
shares
|
$6.79 Million
0.51% of portfolio
|
Q3 2024
Added 398.16%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
2,282,696
shares
|
$6.73 Million
0.01% of portfolio
|
Q3 2024
Reduced 16.26%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,177,600
shares
|
$6.42 Million
0.01% of portfolio
|
Q3 2024
Added 23.39%
|
|
|
Guardian Capital Advisors LP
Toronto, A6 |
Nov 12, 2024 Q3 2024 |
1,786,414
shares
|
$5.27 Million
0.48% of portfolio
|
Q4 2022
Reduced 52.19%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
1,499,640
shares
|
$4.42 Million
0.0% of portfolio
|
Q3 2024
Added 1.79%
|
|
|
Novo Holdings
Hellerup, G7 |
Oct 24, 2024 Q3 2024 |
1,126,915
shares
|
$3.32 Million
0.2% of portfolio
|
Q2 2022
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,096,575
shares
|
$3.23 Million
0.0% of portfolio
|
Q3 2024
Added 0.4%
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
800,000
shares
|
$2.36 Million
0.38% of portfolio
|
Q3 2024
Added 300.0%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
753,887
shares
|
$2.22 Million
0.0% of portfolio
|
Q3 2024
Added 67.27%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
589,653
shares
|
$1.74 Million
0.0% of portfolio
|
Q3 2024
Added 6.8%
|
|
|
Intellectus Partners, LLC
San Francisco, CA |
Nov 06, 2024 Q3 2024 |
545,533
shares
|
$1.61 Million
0.37% of portfolio
|
Q2 2024
Added 0.69%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
420,240
shares
|
$1.24 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.93%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2024 Q3 2024 |
407,384
shares
|
$1.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.36%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
355,747
shares
|
$1.05 Million
0.0% of portfolio
|
Q3 2024
Added 6.43%
|